MFT
CRL icon

Moisand Fitzgerald Tamayo’s Charles River Laboratories CRL Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8
Closed -$1.57K – 690
2023
Q3 		$1.57K Hold
8
– – ﹤0.01% 595
2023
Q2 		$1.68K Sell
8
-4
-33% -$796 ﹤0.01% 576
2023
Q1 		$2.42K Buy
12
+4
+50% +$907 ﹤0.01% 523
2022
Q4 		$1.74K Buy
8
+3
+60% +$655 ﹤0.01% 584
2022
Q3 		$1K Sell
5
-10
-67% -$2.16K ﹤0.01% 583
2022
Q2 		$3K Sell
15
-5
-25% -$1.22K ﹤0.01% 362
2022
Q1 		$6K Buy
+20
New +$6.17K ﹤0.01% 232

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Moisand Fitzgerald Tamayo's CRL Position: Q4 2023 in Review

Moisand Fitzgerald Tamayo sold out of Charles River Laboratories (CRL) in Q4 2023, closing a stake of 8 shares — an estimated $1.57K sold.

Moisand Fitzgerald Tamayo first reported a position in CRL in Q1 2022 and held it in 7 quarters. The position peaked at $6K in Q1 2022. 634 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

  • Moisand Fitzgerald Tamayo reported no remaining Charles River Laboratories position as of Q4 2023 after selling out during the quarter.
  • Moisand Fitzgerald Tamayo sold 8 Charles River Laboratories shares in Q4 2023, an estimated $1.57K.
  • Moisand Fitzgerald Tamayo first reported a position in Charles River Laboratories in Q1 2022 and held it in 7 quarters.
  • Moisand Fitzgerald Tamayo's Charles River Laboratories position peaked at $6K in Q1 2022.
  • 634 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q4 2023, filed 18 Jan 2024.